- Home
- MEDP vs ICLR Comparison
MEDP vs ICLR Comparison
Compare MEDP & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- ICLR
- Stock Information
- Founded
- MEDP 1992
- ICLR 1990
- Country
- MEDP United States
- ICLR Ireland
- Employees
- MEDP N/A
- ICLR N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MEDP Health Care
- ICLR Health Care
- Exchange
- MEDP Nasdaq
- ICLR Nasdaq
- Market Cap
- MEDP 13.4B
- ICLR 14.3B
- IPO Year
- MEDP 2016
- ICLR 1998
- Fundamental
- Price
- MEDP $593.52
- ICLR $162.73
- Analyst Decision
- MEDP Hold
- ICLR Buy
- Analyst Count
- MEDP 12
- ICLR 15
- Target Price
- MEDP $465.18
- ICLR $205.07
- AVG Volume (30 Days)
- MEDP 330.7K
- ICLR 963.3K
- Earning Date
- MEDP 10-22-2025
- ICLR 10-22-2025
- Dividend Yield
- MEDP N/A
- ICLR N/A
- EPS Growth
- MEDP 25.36
- ICLR N/A
- EPS
- MEDP 14.32
- ICLR 7.47
- Revenue
- MEDP $2,358,373,000.00
- ICLR $8,102,602,000.00
- Revenue This Year
- MEDP $21.48
- ICLR N/A
- Revenue Next Year
- MEDP $11.90
- ICLR $0.89
- P/E Ratio
- MEDP $41.21
- ICLR $21.70
- Revenue Growth
- MEDP 13.88
- ICLR N/A
- 52 Week Low
- MEDP $250.05
- ICLR $125.10
- 52 Week High
- MEDP $625.00
- ICLR $228.29
- Technical
- Relative Strength Index (RSI)
- MEDP 61.33
- ICLR 40.46
- Support Level
- MEDP $573.07
- ICLR $155.00
- Resistance Level
- MEDP $609.13
- ICLR $167.43
- Average True Range (ATR)
- MEDP 17.50
- ICLR 6.33
- MACD
- MEDP -2.71
- ICLR -0.64
- Stochastic Oscillator
- MEDP 55.78
- ICLR 30.91
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.